Apr 24 |
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
|
Apr 2 |
HeartSciences to Present at the LD Micro Invitational XIV Conference
|
Mar 26 |
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
|
Mar 16 |
Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023)
|
Mar 14 |
Recap: Heart Test Laboratories Q3 Earnings
|
Mar 14 |
Heart Test Laboratories reports Q3 results
|
Mar 14 |
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
|
Mar 12 |
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
|
Mar 6 |
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
|
Mar 5 |
Heart Test Laboratories files to sell 34.68M shares for holders
|